Capital Market Strategies’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $416K | Hold |
1,027
| – | – | 0.29% | 66 |
|
|
2025
Q1 | $511K | Sell |
1,027
-163
| -14% | -$81.1K | 0.34% | 56 |
|
|
2024
Q4 | $619K | Sell |
1,190
-8
| -0.7% | -$4.16K | 0.36% | 56 |
|
|
2024
Q3 | $741K | Hold |
1,198
| – | – | 0.45% | 44 |
|
|
2024
Q2 | $662K | Sell |
1,198
-52
| -4% | -$28.8K | 0.42% | 46 |
|
|
2024
Q1 | $727K | Hold |
1,250
| – | – | 0.55% | 44 |
|
|
2023
Q4 | $663K | Buy |
1,250
+1
| +0.1% | +$531 | 0.58% | 43 |
|
|
2023
Q3 | $624K | Sell |
1,249
-103
| -8% | -$51.5K | 0.62% | 37 |
|
|
2023
Q2 | $705K | Buy |
+1,352
| New | +$705K | 0.65% | 36 |
|
|
2023
Q1 | – | Sell |
-1,338
| Closed | -$737K | – | 122 |
|
|
2022
Q4 | $737K | Hold |
1,338
| – | – | 0.79% | 32 |
|
|
2022
Q3 | $679K | Buy |
1,338
+34
| +3% | +$17.3K | 0.76% | 33 |
|
|
2022
Q2 | $708K | Hold |
1,304
| – | – | 0.74% | 34 |
|
|
2022
Q1 | $770K | Buy |
1,304
+2
| +0.2% | +$1.18K | 0.67% | 36 |
|
|
2021
Q4 | $869K | Buy |
+1,302
| New | +$869K | 0.72% | 34 |
|